A Study to Compare the Effect of Omadacycline Versus Moxifloxacin in Healthy Adult Volunteers
Phase 1
Completed
- Conditions
- Healthy Volunteer
- Interventions
- First Posted Date
- 2024-06-17
- Last Posted Date
- 2024-11-01
- Lead Sponsor
- Zai Lab (Hong Kong), Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT06462326
- Locations
- 🇨🇳
The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
A Phase 2 Study of ZL-1102 in Patients With Chronic Plaque Psoriasis
Phase 2
Recruiting
- Conditions
- Plaque Psoriasis
- Interventions
- Drug: ZL-1102 3% w/w gel BID for 16 weeksDrug: ZL-1102 3% w/w gel QD for 16 weeksDrug: Placebo ZL-1102 0% w/w gel BID for 16 weeksDrug: Placebo ZL-1102 0% w/w gel QD for 16 weeksDrug: ZL-1102 1% w/w gel BID for 16 weeks
- First Posted Date
- 2024-04-24
- Last Posted Date
- 2024-11-05
- Lead Sponsor
- Zai Lab (Hong Kong), Ltd.
- Target Recruit Count
- 250
- Registration Number
- NCT06380907
- Locations
- 🇦🇺
Zai Lab Site 5013, Phillip, Australian Capital Territory, Australia
🇦🇺Zai Lab Site 5021, Kogarah, New South Wales, Australia
🇦🇺Zai Lab Site 5016, Kotara, New South Wales, Australia
A Phase 3b Randomized, Double-blind, Multi-center Study to Compare the Safety and Efficacy of Omadacycline to Moxifloxacin for Treating Adult Subjects With CABP
Phase 3
Recruiting
- Conditions
- Community-acquired Bacterial Pneumonia
- Interventions
- First Posted Date
- 2023-12-08
- Last Posted Date
- 2024-06-14
- Lead Sponsor
- Zai Lab (Hong Kong), Ltd.
- Target Recruit Count
- 100
- Registration Number
- NCT06162286
- Locations
- 🇨🇳
The Third Hospital of Changsha/Respiratory and Critical Care Medicine Department, Changsha, China
🇨🇳Kunming First People's Hospital/Respiratory Medicine, Kunming, China
🇨🇳Shanghai Pulmonary Hospital/Respiratory and Critical Care Medicine Department, Shanghai, China
A Phase 1 Study of ZL-1218 in Subjects With Advanced Solid Tumors
- First Posted Date
- 2023-05-16
- Last Posted Date
- 2025-01-17
- Lead Sponsor
- Zai Lab (Hong Kong), Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT05859464
- Locations
- 🇺🇸
Zai Lab Site 2005, Irvine, California, United States
🇺🇸Zai Lab Site 2007, Detroit, Michigan, United States
🇺🇸Zai Lab Site 2001, Hackensack, New Jersey, United States
© Copyright 2025. All Rights Reserved by MedPath